GS-903. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman J, Miller M, Coakley DF, Lu B, Toole JJ, Cheng AK; for the 903 Study Group. JAMA 2004; 292:191-201.